# EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone

> **NCT03781596** · PHASE4 · UNKNOWN · sponsor: **Claire Daniels** · enrollment: 100 (estimated)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DIAGNOSTIC_TEST:** Retrospective evaluation of endoscopy prior to study drug
- **OTHER:** Symptom Survey
- **OTHER:** Medication Compliance Phone Call
- **DIAGNOSTIC_TEST:** Endoscopy while on study drug
- **OTHER:** Symptom Survey
- **DRUG:** Fluticasone
- **DRUG:** Omeprazole
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03781596
- **Lead sponsor:** Claire Daniels
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-02
- **Primary completion:** 2020-10-02
- **Final completion:** 2022-10-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03781596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03781596, "EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03781596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*